Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Molecular Partners ADR | MOLN | 22. nov 2024 | 5.29 | -2.49 |
Molecular Templates | MTEM | 22. nov 2024 | 0.34 | -11.76 |
Moleculin Biotech | MBRX | 22. nov 2024 | 2.73 | -3.53 |
Molina Healthcare | MOH | 22. nov 2024 | 290.79 | -1.78 |
Molson Coors B | TAP | 22. nov 2024 | 60.36 | -0.18 |
Molson Coors Beverage Company A | TAP-A | 22. nov 2024 | 60.00 | 0.00 |
Momentus A | MNTS | 22. nov 2024 | 0.56 | -2.96 |
Monarch Casino & Resort | MCRI | 22. nov 2024 | 84.42 | +0.96 |
Monday.com | MNDY | 22. nov 2024 | 284.59 | +3.02 |
Mondee | MOND | 22. nov 2024 | 0.99 | +1.21 |
Mondelez International A | MDLZ | 22. nov 2024 | 64.40 | -0.60 |
Moneyhero | MNY | 22. nov 2024 | 1.15 | 0.00 |
MoneyLion A | ML | 22. nov 2024 | 87.18 | +8.65 |
MongoDB A | MDB | 22. nov 2024 | 332.50 | +5.41 |
Monogram Technologies | MGRM | 22. nov 2024 | 1.97 | -0.51 |
Monolithic Power Systems | MPWR | 22. nov 2024 | 580.81 | +1.46 |
Monopar Therapeutics | MNPR | 22. nov 2024 | 20.10 | +1.98 |
Monro | MNRO | 22. nov 2024 | 27.04 | +1.16 |
Monroe Capital | MRCC | 22. nov 2024 | 8.41 | -0.36 |
Monster Beverage | MNST | 22. nov 2024 | 54.06 | +0.15 |
Montauk Renewables | MNTK | 22. nov 2024 | 4.46 | +0.68 |
Monte Rosa Therapeutics | GLUE | 22. nov 2024 | 8.49 | +1.68 |
Montrose Environmental Group | MEG | 22. nov 2024 | 17.89 | -4.94 |
Moodys | MCO | 22. nov 2024 | 480.66 | +0.57 |
Moog A | MOG-A | 22. nov 2024 | 222.56 | +1.02 |
Moog B | MOG-B | 22. nov 2024 | 214.95 | 0.00 |
Moolec Science | MLEC | 22. nov 2024 | 0.89 | +4.58 |
MoonLake Immunotherapeutics | MLTX | 22. nov 2024 | 54.32 | +4.74 |
Morgan Stanley | MS | 22. nov 2024 | 134.69 | -0.22 |
Morgan Stanley China A Share Fund | CAF | 22. nov 2024 | 12.32 | -2.95 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.